Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Molecular diagnostics and mitochondrial dysfunction: a future perspective.

Gabriele Siciliano1, Livia Pasquali, Michelangelo Mancuso

  • 1Department of Neuroscience, Section of Neurology, University of Pisa, Via Roma 67, 56126 Pisa, Italy. g.siciliano@med.unipi.it

Expert Review of Molecular Diagnostics
|July 5, 2008
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Inter-centre heterogeneity, temporal evolution, and factors associated with treatment selection and outcomes in chronic inflammatory demyelinating polyradiculoneuropathy: a multicentre, combined prospective and retrospective observational study.

EClinicalMedicine·2026
Same authorSame journal

Fluid biomarkers in cerebral amyloid angiopathy: current limitations and future directions.

Expert review of molecular diagnostics·2026
Same author

The novel (TCTG)<sub>n</sub> motif in CNBP expanded alleles: composition, dynamics and genotype-phenotype correlation in Myotonic dystrophy type 2 (DM2).

Human genomics·2026
Same author

Mitochondrial abnormalities in idiopathic inflammatory myopathies.

Clinical and experimental rheumatology·2026
Same author

Statins and ribociclib interaction induced necrotising myopathy: a case report and literature review.

Clinical and experimental rheumatology·2026
Same author

Real-world evaluation of the transition between originator and follow-on glatiramer acetate in people with multiple sclerosis: the "GA transition" study.

Multiple sclerosis and related disorders·2026
Same journal

Navigating PD-L1 testing in immuno-oncology: analytical robustness, clinical validation, and the role of the VENTANA SP263 assay.

Expert review of molecular diagnostics·2026
Same journal

Extracellular vesicles as diagnostic and prognostic biomarkers in non-small cell lung cancer.

Expert review of molecular diagnostics·2026
Same journal

Explainable epigenetic aging clocks: an overview of existing AI models and approaches.

Expert review of molecular diagnostics·2026
Same journal

Neuro-axonal injury biomarker serum neurofilament light chain is associated with osteoarthritis: a dual-cohort study from NHANES and UK Biobank.

Expert review of molecular diagnostics·2026
Same journal

Diagnostics and novel laboratory approaches to combat <i>Neisseria gonorrhoeae</i> antimicrobial resistance.

Expert review of molecular diagnostics·2026
See all related articles

Molecular diagnostics for mitochondrial diseases are advancing rapidly. New biological and biophysical techniques enhance understanding of disease mechanisms and patient management.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Genetics

Background:

  • Mitochondrial diseases are complex genetic disorders with significant diagnostic challenges.
  • Recent advancements in biological, biochemical, and biophysical techniques have improved the study of these diseases.

Purpose of the Study:

  • To review the current state of molecular diagnostics in mitochondrial diseases.
  • To highlight the impact of novel investigative technologies on understanding disease pathophysiology and management.

Main Methods:

  • Review of current literature on molecular diagnostic techniques.
  • Analysis of biological, biochemical, and biophysical investigation methods.
  • Integration of in vivo and in vitro research findings.

Related Experiment Videos

Main Results:

  • Significant progress in molecular genetic characterization of mitochondrial diseases.
  • Emerging laboratory approaches provide new molecular insights.
  • Identification of key molecules influencing clinical phenotypes and cell damage mechanisms.

Conclusions:

  • Molecular diagnostics are crucial for advancing the understanding and management of mitochondrial diseases.
  • Novel technologies are continuously enriching the field with new diagnostic and therapeutic insights.